Mirae Asset Global Investments Co., Ltd. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$876,908
-5.9%
91,060
+3.9%
0.00%0.0%
Q2 2023$932,312
+2.2%
87,600
+1.0%
0.00%0.0%
Q1 2023$912,074
+16.5%
86,699
+37.3%
0.00%0.0%
Q4 2022$782,652
+19.7%
63,168
+0.1%
0.00%0.0%
Q3 2022$654,000
+24.1%
63,110
+38.1%
0.00%
+100.0%
Q2 2022$527,000
-54.0%
45,700
-39.0%
0.00%
-96.2%
Q4 2016$1,145,000
+30.7%
74,858
+35.8%
0.03%
+44.4%
Q3 2016$876,000
+21.2%
55,136
-0.2%
0.02%
-5.3%
Q2 2016$723,000
-47.3%
55,259
-56.0%
0.02%
-48.6%
Q1 2016$1,373,000
-3.8%
125,484
+1.9%
0.04%
-21.3%
Q4 2015$1,427,000
+12.4%
123,127
+1.1%
0.05%
-9.6%
Q3 2015$1,270,000
-10.9%
121,843
+3.1%
0.05%
+13.0%
Q2 2015$1,425,000
-11.0%
118,188
+18.1%
0.05%
-14.8%
Q1 2015$1,602,000
+29.0%
100,100
+23.5%
0.05%
+20.0%
Q4 2014$1,242,000
+15.6%
81,078
-2.2%
0.04%
+15.4%
Q3 2014$1,074,00082,9080.04%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders